IMMUNOVANT, INC. — Balance Sheet Charts
4 snapshots of history · ending 2024-03-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Capital Structure (LT Debt / Cash / Equity)
Total Assets
$666M
Current Assets
$666M
Cash & Equivalents
$635M
Receivables
$5M
Net PPE
$462K
Total Liabilities
$49M
Current Liabilities
$49M
Account Payables
$7M
Stockholders Equity
$618M
Retained Earnings
$-826M
Operating Lease ROU Asset
$133K
Operating Lease Liability
$138K